Compositions and methods for using alternating electric fields to disrupt lipid capsules
Disclosed are methods of delivering a therapeutic to a target site of a subject comprising administering a lipid capsule to a target site of a subject, wherein the lipid capsule comprises a therapeutic agent; and applying an alternating electric field, at a frequency for a period of time, to the target site of the subject, wherein the alternating electric field releases the therapeutic from lipid capsule at the target site of the subject. Disclosed are methods of increasing target site specific release of a therapeutic agent in a subject comprising administering a lipid capsule to a target site of a subject, wherein the lipid capsule comprises a therapeutic agent; and applying an alternating electric field, at a frequency for a period of time, to the target site of the subject, wherein the alternating electric field releases the therapeutic agent from the lipid capsule at the target site of the subject, thereby increasing the target site specific release of the therapeutic agent. Disclosed are methods of treating comprise administering a lipid capsule to a target site of a subject in need thereof, wherein the lipid capsule comprises a therapeutic agent; and applying an alternating electric field, at a frequency for a period of time, to the target site of the subject in need thereof, wherein the alternating electric field releases the therapeutic agent from the lipid capsule at the target site of the subject in need thereof. Disclosed are methods of killing a cell comprising administering a lipid capsule to a target site, wherein the lipid capsule comprises a therapeutic agent; and applying an alternating electric field for a period of time, to the target site, wherein the alternating electric field releases the therapeutic agent from the lipid capsule at the target site, wherein the target site comprises a cell, wherein the therapeutic kills the cell.
1 . A method of delivering a therapeutic to a target site of a subject comprising:
a. administering a lipid capsule to a target site of a subject, wherein the lipid capsule comprises a therapeutic agent; and
b. applying an alternating electric field, at a frequency for a period of time, to the target site of the subject, wherein the alternating electric field releases the therapeutic from the lipid capsule at the target site of the subject.
2 . The method of claim 1 , wherein the lipid capsule is loaded with the therapeutic agent.
3 . The method of claim 1 , wherein the therapeutic agent is encapsulated in the lipid capsule.
4 . The method of claim 1 , wherein the therapeutic agent is conjugated to the lipid capsule.
5 . The method of claim 1 , wherein the therapeutic agent is a small molecule, nucleic acid, carbohydrate, lipid, peptide, antibody, or antibody fragment.
6 . The method of claim 1 , wherein the lipid capsule comprises an outer surface, wherein the outer surface comprises a lipid layer.
7 . The method of claim 6 , wherein the lipid layer is a lipid bilayer.
8 . The method of claim 1 , wherein the lipid capsule comprises phospholipids.
9 . The method of claim 1 , wherein the therapeutic is an anti-cancer therapeutic, an anti-viral therapeutic, an anti-bacterial therapeutic, an anti-fungal therapeutic, a pro-inflammatory therapeutic, or an anti-inflammatory therapeutic.
10 . The method of claim 9 , wherein the anti-cancer therapeutic is a chemotherapeutic agent.
11 . The method of claim 1 , wherein the lipid capsule enters the target site.
12 . The method of claim 1 , wherein the subject has cancer, an infection, an inflammatory disorder, or is immune suppressed.
13 . The method of claim 1 , wherein the target site comprises a cell.
14 . The method of claim 13 , wherein the cell is a cancer cell, a pathogen-infected cell, or an immune cell.
15 . The method of claim 13 , wherein the lipid capsule enters the cancer cell or pathogen-infected cell prior to releasing the therapeutic.
16 . The method of claim 1 , further comprising applying a second alternating electric field at a second frequency to the target site prior to, during or after step a).
17 . The method of claim 1 , wherein the frequency of the alternating electric field is between 100 and 500 kHz.
18 . The method of claim 1 , wherein the lipid capsule is administered prior to, during or after exposing the target site to the alternating electric field.
19 . A method of increasing target site specific release of a therapeutic agent in a subject comprising:
a. administering a lipid capsule to a target site of a subject, wherein the lipid capsule comprises a therapeutic agent; and
b. applying an alternating electric field, at a frequency for a period of time, to the target site of the subject,
wherein the alternating electric field releases the therapeutic agent from the lipid capsule at the target site of the subject, thereby increasing the target site specific release of the therapeutic agent.
20 . A method of treating a subject in need thereof comprising
a. administering a lipid capsule to a target site of a subject in need thereof, wherein the lipid capsule comprises a therapeutic agent; and
b. applying an alternating electric field, at a frequency for a period of time, to the target site of the subject in need thereof,
wherein the alternating electric field releases the therapeutic agent from the lipid capsule at the target site of the subject in need thereof.